NCT03646825

Brief Summary

Observational study to see the effect of use of natural Antioxidant supplement on sperm DNA fragmentation. Subjects will take the natural antioxidant for 3 months prior to repeat testing.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
54

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Aug 2018

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2018

Completed
22 days until next milestone

First Submitted

Initial submission to the registry

August 23, 2018

Completed
1 day until next milestone

First Posted

Study publicly available on registry

August 24, 2018

Completed
3.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 15, 2022

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2022

Completed
Last Updated

February 23, 2023

Status Verified

February 1, 2023

Enrollment Period

3.9 years

First QC Date

August 23, 2018

Last Update Submit

February 22, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Sperm DNA fragmentation

    Direct comparison of sperm DNA fragmentation pre and post natural antioxidant exposure

    12 weeks

Study Arms (1)

Treatment group

Male patients exposed to antioxidant for 12 weeks

Dietary Supplement: Natural Antioxidant supplement

Interventions

1 capsule orally three times a day for 12 weeks

Treatment group

Eligibility Criteria

Age18 Years - 55 Years
Sexmale
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Male patients pursuing IVF for treatment of infertility

You may qualify if:

  • Sperm Chromatin \>16%, sufficient ejaculate sperm for ICSI

You may not qualify if:

  • Severe male factor infertility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Colorado Center for Reproductive Medicine

Lone Tree, Colorado, 80124, United States

Location

Study Officials

  • Rachel Makloski

    Study Coordinator

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 23, 2018

First Posted

August 24, 2018

Study Start

August 1, 2018

Primary Completion

June 15, 2022

Study Completion

October 1, 2022

Last Updated

February 23, 2023

Record last verified: 2023-02

Data Sharing

IPD Sharing
Will not share

Locations